A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

10.1038/s41467-018-03441-3

Saved in:
Bibliographic Details
Main Authors: Ladds, M.J.G.W, Van Leeuwen, I.M.M, Drummond, C.J
Other Authors: MEDICINE
Format: Article
Published: Nature Publishing Group 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/178423
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-178423
record_format dspace
spelling sg-nus-scholar.10635-1784232024-05-08T09:51:10Z A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage Ladds, M.J.G.W Van Leeuwen, I.M.M Drummond, C.J MEDICINE antineoplastic agent dihydroorotate dehydrogenase dihydroorotate dehydrogenase inhibitor hz 00 hz 05 nutlin 3 protein p53 unclassified drug antineoplastic agent enzyme inhibitor indazole derivative oxidoreductase protein p53 biodegradation cancer cell chemical compound crystal structure enzyme enzyme activity growth inhibitor protein tumor animal cell animal experiment animal model antineoplastic activity Article cancer cell cancer combination chemotherapy cell cycle S phase cell killing chirality controlled study crystal structure drug identification drug mechanism enantiomer enzyme inhibition human human cell in vivo study malignant neoplasm melanoma mouse nonhuman protein degradation protein denaturation protein synthesis tumor growth antagonists and inhibitors cell cycle cell proliferation chemistry drug effect enzymology genetics metabolism neoplasm protein degradation tumor cell line Antineoplastic Agents Cell Cycle Cell Line, Tumor Cell Proliferation Enzyme Inhibitors Humans Indazoles Neoplasms Oxidoreductases Acting on CH-CH Group Donors Proteolysis Tumor Suppressor Protein p53 10.1038/s41467-018-03441-3 Nature Communications 9 1 1107 2020-10-20T09:53:37Z 2020-10-20T09:53:37Z 2018 Article Ladds, M.J.G.W, Van Leeuwen, I.M.M, Drummond, C.J (2018). A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications 9 (1) : 1107. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-018-03441-3 2041-1723 https://scholarbank.nus.edu.sg/handle/10635/178423 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Nature Publishing Group Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic antineoplastic agent
dihydroorotate dehydrogenase
dihydroorotate dehydrogenase inhibitor
hz 00
hz 05
nutlin 3
protein p53
unclassified drug
antineoplastic agent
enzyme inhibitor
indazole derivative
oxidoreductase
protein p53
biodegradation
cancer
cell
chemical compound
crystal structure
enzyme
enzyme activity
growth
inhibitor
protein
tumor
animal cell
animal experiment
animal model
antineoplastic activity
Article
cancer cell
cancer combination chemotherapy
cell cycle S phase
cell killing
chirality
controlled study
crystal structure
drug identification
drug mechanism
enantiomer
enzyme inhibition
human
human cell
in vivo study
malignant neoplasm
melanoma
mouse
nonhuman
protein degradation
protein denaturation
protein synthesis
tumor growth
antagonists and inhibitors
cell cycle
cell proliferation
chemistry
drug effect
enzymology
genetics
metabolism
neoplasm
protein degradation
tumor cell line
Antineoplastic Agents
Cell Cycle
Cell Line, Tumor
Cell Proliferation
Enzyme Inhibitors
Humans
Indazoles
Neoplasms
Oxidoreductases Acting on CH-CH Group Donors
Proteolysis
Tumor Suppressor Protein p53
spellingShingle antineoplastic agent
dihydroorotate dehydrogenase
dihydroorotate dehydrogenase inhibitor
hz 00
hz 05
nutlin 3
protein p53
unclassified drug
antineoplastic agent
enzyme inhibitor
indazole derivative
oxidoreductase
protein p53
biodegradation
cancer
cell
chemical compound
crystal structure
enzyme
enzyme activity
growth
inhibitor
protein
tumor
animal cell
animal experiment
animal model
antineoplastic activity
Article
cancer cell
cancer combination chemotherapy
cell cycle S phase
cell killing
chirality
controlled study
crystal structure
drug identification
drug mechanism
enantiomer
enzyme inhibition
human
human cell
in vivo study
malignant neoplasm
melanoma
mouse
nonhuman
protein degradation
protein denaturation
protein synthesis
tumor growth
antagonists and inhibitors
cell cycle
cell proliferation
chemistry
drug effect
enzymology
genetics
metabolism
neoplasm
protein degradation
tumor cell line
Antineoplastic Agents
Cell Cycle
Cell Line, Tumor
Cell Proliferation
Enzyme Inhibitors
Humans
Indazoles
Neoplasms
Oxidoreductases Acting on CH-CH Group Donors
Proteolysis
Tumor Suppressor Protein p53
Ladds, M.J.G.W
Van Leeuwen, I.M.M
Drummond, C.J
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
description 10.1038/s41467-018-03441-3
author2 MEDICINE
author_facet MEDICINE
Ladds, M.J.G.W
Van Leeuwen, I.M.M
Drummond, C.J
format Article
author Ladds, M.J.G.W
Van Leeuwen, I.M.M
Drummond, C.J
author_sort Ladds, M.J.G.W
title A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
title_short A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
title_full A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
title_fullStr A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
title_full_unstemmed A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
title_sort dhodh inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
publisher Nature Publishing Group
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/178423
_version_ 1800914498562818048